Yousef Javadzadeh

Yousef Javadzadeh


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YJYousef Javadzadeh
Yousef Javadzadeh
BJBaharak Jafari-Navimipour
Baharak Jafari-Navimipour
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MGMohammadali Poursharifi Ghourichay
Mohammadali Poursharifi Ghourichay
Seyed hossein KiaieSeyed hossein Kiaie
Seyed hossein Kiaie
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
YJYousef Javadzadeh
Yousef Javadzadeh
Orally disintegrating tablets (ODTs) rapidly disintegrate or dissolve in the oral cavity without using water. Demand for ODTs has increased, and the field has overgrown in the pharmaceutical industry and academia. It is reported that ODTs have several advantages over other conventional tablets. Since some of them are absorbed from the mouth, pharynx, and esophagus as the saliva passes down into the stomach, in such cases, the bioavailability of the drug improves meaningfully. Furthermore, the immediate release property of ODTs makes them a popular oral dosage form in patients with swallowing challenges, children, and for cases with a need for rapid onset of action. The current review article explains the features of active ingredients and excipients used in the formulation of ODTs, discusses multiple ODT formulation and preparation techniques with their merits and demerits, and also, offers remedies for problems associated with ODTs. Moreover, quality control steps and required considerations are presented.

21 September 2015 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
HEHossein Ali Ebrahimi
Hossein Ali Ebrahimi
YJYousef Javadzadeh
Yousef Javadzadeh
MHMehrdad Hamidi
Mehrdad Hamidi
MJMohammad Barzegar Jalali
Mohammad Barzegar Jalali
Repaglinide is an efficient anti-diabetic drug which is prescribed widely as multi-dosage oral daily regimens. Due to the low compliance inherent to each m

1 December 2010 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
YJYousef Javadzadeh
Yousef Javadzadeh
FAFatemeh Ahadi
Fatemeh Ahadi
SDSoodabeh Davaran
Soodabeh Davaran
GMGhobad Mohammadi
Ghobad Mohammadi
ASAraz Sabzevari
Araz Sabzevari
KAKhosro Adibkia
Khosro Adibkia

1 March 2011 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
KAKhosro Adibkia
Khosro Adibkia
YJYousef Javadzadeh
Yousef Javadzadeh
SDSiavoush Dastmalchi
Siavoush Dastmalchi
GMGhobad Mohammadi
Ghobad Mohammadi
FNFatemeh Kari Niri
Fatemeh Kari Niri
MAMahmood Alaei-Beirami
Mahmood Alaei-Beirami

1 December 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SGSaeed Ghanbarzadeh
Saeed Ghanbarzadeh
RHReza Hariri
Reza Hariri
MKMaryam Kouhsoltani
Maryam Kouhsoltani
JSJavad Shokri
Javad Shokri
YJYousef Javadzadeh
Yousef Javadzadeh
HHHamed Hamishehkar
Hamed Hamishehkar